Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Cepheid (NASDAQ: CPHD) acted responsibly on behalf of investors’ profitability in the planned $4 billion sale to Danaher Corporation (NYSE: DHR).

On September 6, 2016, Cepheid (NASDAQ: CPHD) and Danaher Corporation (NYSE: DHR) announced that they had entered into a merger agreement. Under the terms of the merger agreement, Danaher will offer Cepheid shareholders $53.00 per share in cash for all outstanding shares.    

Based in Sunnyvale, CA, and founded in 1996 Cepheid develops, manufactures, and markets integrated systems for testing in the clinical and non-clinical markets.

The investigation focuses on whether NASDAQ: CPHD investors received the highest price and whether the directors of Cepheid acted in the best interest of Cepheid company and its shareholders.   

If you purchased Cepheid (NASDAQ: CPHD) prior to September 6, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185